Effectiveness of HEPA Filters at Removing Infectious SARS-CoV-2 from the Air | mSphere
Covid
Efficacy of Ventilation, HEPA Air Cleaners, Universal Masking, and Physical Distancing for Reducing Exposure to Simulated Exhaled Aerosols in a Meeting Room
Performance analysis of portable HEPA filters and temporary plastic anterooms on the spread of surrogate coronavirus
Ventilation and air cleaning to limit aerosol particle concentrations in a gym during the COVID-19 pandemic
Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward
Use of portable air cleaners to reduce aerosol transmission on a hospital coronavirus disease 2019 (COVID-19) ward - PubMed
Real-World Data Show That Filters Clean Covid-Causing Virus From Air
Testing mobile air purifiers in a school classroom: Reducing the airborne transmission risk for SARS-CoV-2
Efficacy of Portable Air Cleaners and Masking for Reducing Indoor Exposure to Simulated Exhaled SARS-CoV-2 Aerosols — United States, 2021 - mm7027e1-H.pdf
Air purification — HEPA
CLAIRE – Clean air for everyone
Ventilation during COVID-19 in a school for students with intellectual and developmental disabilities (IDD)
Frontiers | Efficiency of Air Purifiers at Removing Air Pollutants in Educational Facilities: A Preliminary Study
CU Boulder, UCLA study finds COVID-19 protective measures saved 800,000 lives
Long covid may cause cognitive decline of about six IQ points, study finds
Even fully recovered survivors of mild COVID can lose IQ points, study suggests | CIDRAP
Exclusive: Study Finds COVID Harmed Cognitive Skills of Students — and Teachers
Pandemic Mitigation Collaborative - COVID-19 Forecasting Model
R&D for long COVID is collapsing
Analysis reveals global post-covid surge in infectious diseases
Public Service Announcement - WHN
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination
UT researchers say they found an antibody that protects against all COVID-19 variants
Scientists Develop Game-Changing Needle-Free COVID-19 Intranasal Vaccine
COVID-19 Update: An EUA for Pemivibart (Pemgarda) for Pre-Exposure Prophylaxis | The Medical Letter Inc.
Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19
Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19
NasalCrom for Neuroinflammation?
Study: Long COVID affects 8% of those with COVID-19, is more common in women